Substituted thieno[2,3-b]pyrazine compounds as modulators of B-Raf kinase activity
US8669256B2 · kind B2 · utility
1Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 23, 2011 |
| Grant date | Mar 11, 2014 |
| Priority date | — |
| Expiry date | May 23, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to compounds according to general Formula (I) or a pharmaceutically acceptable salt thereof. The compounds can be used for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.